Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00499850
Status:
COMPLETED
Last Update Posted:
2016-08-25
First Post:
2007-07-10
Brief Title:
Phase I FOLFOX Combination
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Study Overview
Official Title:
A Phase IOpen Label Study to Assess the Safety and Tolerability of ZD6474 in Combination With 5-Fluorouracil Leucovorin and Oxaliplatin mFOLFOX6 as First and Second Line Therapy in Patients With Advanced Colorectal Adenocarcinoma
Status:
COMPLETED
Status Verified Date:
2016-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Phase Iopen label study to assess the safety and tolerability of ZD6474 in combination with 5-Fluorouracil Leucovorin and Oxaliplatin mFOLFOX6 as first and second line therapy in patients with advanced colorectal adenocarcinoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None